J Breast Cancer.  2006 Jun;9(2):121-126. 10.4048/jbc.2006.9.2.121.

Utiliy of Breast Sentinel Lymph Node Biopsy Using the Day-Before or the Same-Day Subareolar Injection of (99m)Tc-Tin Colloid

Affiliations
  • 1Department of Surgery, Korea Cancer Center Hospital, Seoul, Korea. nohwoo@kcch.re.kr
  • 2Department of Pathology, Korea Cancer Center Hospital, Seoul, Korea.
  • 3Department of Nuclear Medicine, Korea Cancer Center Hospital, Seoul, Korea.

Abstract

PURPOSE
The aims of this study were to examine the feasibility of sentinel lymph node (SLN) biopsy using the day-before-surgery or the same-day subareolar injection of (99m)Tc-Tin colloid, and to evaluate the accuracy of performing intraoperative multiple frozen section diagnosis of the SLN for breast cancer.
METHODS
From Jul. 2003 to Feb. 2004, a total of 81 women with clinically node negative breast cancer underwent SLN biopsy and this was followed by axillary lymph node dissection at the Korea Cancer Center Hospital. 2-2.5mCi of (99m)Tc-Tin colloid was injected intradermally in the outer upper edge of the areola on the day before or the same day of surgery, and lymphoscintigraphy was then obtained. The time interval between the injection of tracer and SLN biopsy varied from 1 hour to 20 hours. Intraoperatively, the status of the SLNs was examined by multiple frozen section diagnosis and all the SLNs were subjected to serial sectioning for Hematoxylin-eosin staining and immunohistochemical staining for cytokeratin. After removal of the SLNs, standard level I and II axillary dissection was performed in all patients.
RESULTS
In 26 patients (32.1%), the SLNs were positive for tumor cells among these 26 patients. 16 patients (61.5%) results showed that the SLNs were the only metastatic nodes. Two cases of false negative findings were identified. The sensitivity and specificity were 92.9% and 100% respectively. In the second half of this study, no false-negative cases were found in 41 consecutive patients.
CONCLUSION
The results of SLN biopsy using the day-before-surgery or same-day subareolar injection of (99m)Tc-Tin colloid were excellent for identification of the SLNs. This technique does not interfere with effective treatment in the operating room because the time interval between the injection and surgery did not affect the results of SLN biopsy. Intraoperative multiple frozen section diagnosis of SLNs was readily available, and this was highly accurate for assessing the status of SLNs

Keyword

Breast neoplasm; Frozen section; Sentinel lymph node; Technetium Tc(99m)Tin colloid

MeSH Terms

Biopsy
Breast Neoplasms
Breast*
Colloids*
Diagnosis
Female
Frozen Sections
Humans
Keratins
Korea
Lymph Node Excision
Lymph Nodes
Lymphoscintigraphy
Operating Rooms
Sensitivity and Specificity
Sentinel Lymph Node Biopsy*
Colloids
Keratins

Cited by  2 articles

Predictors of Non-sentinel Lymph Node Metastasis in Breast Cancer
Yang Hee Kim, Min Suk Kim, Nam Sun Paik, Nan Mo Moon, Woo Chul Noh
J Breast Cancer. 2007;10(1):95-100.    doi: 10.4048/jbc.2007.10.1.95.

A Comparison of Outcomes for the Patients with Pathologically Node-negative Breast Cancer and Who Were Treated Either with Sentinel Lymph Node Biopsy Only or with Conventional Axillary Lymph Node Dissection
Hyun-Ah Kim, Eun-Jeong Jo, Min-Suk Kim, Yang-Hee Kim, Nam-Sun Paik, Nan-Mo Moon, Jong-Inn Lee, Kwang Mo Yang, Woo-Chul Noh
J Breast Cancer. 2009;12(4):265-271.    doi: 10.4048/jbc.2009.12.4.265.


Reference

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989. 63:181–187.
Article
2. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intra operative lymphatic mapping for early stage melanoma. Arch Surg. 1992. 127:392–399.
Article
3. Giuliano AE, Dale PS, Turner RR. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995. 222:394–401.
Article
4. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997. 15:2345–2350.
Article
5. Park JM, Jin SH, Kim MW, Yim H, Park CH, Chung KI, et al. Sentinel lymph node biopsy using technetium-99m antimony sulfide colloid and isosulfan blue dye in breast cancer patients. J Korean Breast Cancer Soc. 2002. 5:168–174.
Article
6. Kim SW, Han WS, Park IA, Chung JK, Yeo JS, Moon WK, et al. Prospective study of 162 sentinel lymph node biopsies in breast cancer: Usefulness of ultrasonography in patients selection. J Korean Breast Cancer Soc. 2003. 6:103–108.
Article
7. Choi JW, Lee HD, Park BW, Jung WH, Oh KK, Ryu YK. Experiences with sentinel lymphadenectomy in 157 cases of breast carcinoma. J Korean Breast Cancer Soc. 2002. 5:38–45.
Article
8. Imoto S, Murakami K, Ikeda H, Fukita H, Moriyama N. Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer. Ann Nucl Med. 1999. 13:325–329.
Article
9. Shimazu K, Tamaki Y, Taguchi T, Takamura Y, Noguchi S. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery. 2002. 131:277–286.
Article
10. Linehan DC, Hill AD, Akhurst T, Yeung H, Yeh SD, Tran KN, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol. 1999. 6:450–454.
Article
11. Kern KA, Rosenberg RJ. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg. 2000. 191:479–489.
Article
12. D'Eredita' G, Ferrarese F, Cecere V, Massa ST, de Carne F, Fabiano G. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 2003. 10:942–947.
13. Kim HA, Lee JH, Moon BI, Choi KJ, Sung SH, Chio HY, et al. The efficacy of sentinel node biopsy using subareolar injection of radioactive material in breast cancer. J Korean Breast Cancer Soc. 2003. 6:180–185.
Article
14. Zogakis TG, Wetherille RE, Christensen RD, Ose KJ, Friedman JD, Colbert M, et al. Intraoperative subareolar injection of 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification. Ann Surg Oncol. 2005. 12:167–172.
Article
15. Ellis RL, Seifert PJ, Neal CE, Pavolka KR, Mann JL, Malafa MP, et al. Periareolar injection for localization of sentinel nodes in breast cancer patients. Breast J. 2004. 10:94–100.
Article
16. Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg. 1999. 65:500–506.
17. Teng S, Dupont E, McCann C, Wang J, Bolano M, Durand K, et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg. 2000. 66:574–578.
18. Pargaonkar AS, Beissner RS, Snyder S, Speights VO Jr. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med. 2003. 127:701–705.
Article
19. Lee KI, Jeong J, Chang HS, Park BW, Jung WH, Hong SW, et al. Intraoperative examination of sentinel lymph nodes using rapid cytokeratin immunohistochemical staining in breast cancer patients. J Korean Breast Cancer Soc. 2004. 7:154–160.
Article
20. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994. 220:391–398.
Article
Full Text Links
  • JBC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr